Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics – Pharmaceutical Technology Magazine (press release) (blog)
|
Oxford Genetics Licenses CRISPR Gene Editing Technology from ERS Genomics
Pharmaceutical Technology Magazine (press release) (blog) On May 9, 2017, Oxford Genomics announced that it has signed a non-exclusive licensing agreement with ERS Genomics to access its foundational intellectual property related to CRISPR-Cas9 gene-editing technology. The agreement grants Oxford … |
